基本信息
浏览量:252
职业迁徙
个人简介
Research Interests
he leads the Familial Breast Cancer Research Unit. Dr. Narod is renowned for his resesarch on the BRCA1 and BRCA2 genes, that when mutated, substantially increase a woman’s lifetime risk of breast or ovarian cancer. He also studies various aspects of cancer prevention and screening. With more than 550 peer-reviewed publications and an h-index of 85, he is the most-cited researcher in the world in the field of breast cancer. In 2012, Dr. Narod was elected a Fellow of the Royal Society of Canada.
Dr. Narod has studied hereditary breast cancer since 1987 at the International Agency in Research in Cancer in Lyon France with Dr Gilbert Lenoir. He reactivated his career in Canada in 1995 at McGill University under Dr David Rosenblatt working with Dr Patricia Tonin and Dr William Foulkes. He is a co-discoverer of the BRCA1 and BRCA2 genes, and since their discoveries in 1994 and 1995, he has studied the distribution of mutations worldwide. His team have identified founder mutations in the Ashkenazi-Jewish, French-Canadian, and Bahamian populations. His recent research has revealed that one per cent of Jewish women in Ontario carry a BRCA1/2 mutation, that half of these women are not eligible for provincially-funded genetic testing. Most recently, Dr. Narod’s collaborative research showed that women in Poland with BRCA1mutations have a 46 per cent lower risk of breast cancer than women in North America with the same mutation. Dr. Narod’s seminal discoveries have stemmed from both his laboratory and his database – the largest of its kind – of over13,000 women. He has advanced cancer genetics around the world through collaboration with experts in over 30 countries in North America, Asia, Europe, the Caribbean, and Latin America. His research has been instrumental in understanding the role of hereditary factors in breast and ovarian cancer, and he continues to translate the emerging knowledge into more effective strategies for cancer prevention, detection and management. Dr Narod’s influence during the last 15 years has profoundly shaped current knowledge of how to assess breast and ovarian cancer risk and reduce its mortality amongst carriers of BRCA1/2 mutations.
he leads the Familial Breast Cancer Research Unit. Dr. Narod is renowned for his resesarch on the BRCA1 and BRCA2 genes, that when mutated, substantially increase a woman’s lifetime risk of breast or ovarian cancer. He also studies various aspects of cancer prevention and screening. With more than 550 peer-reviewed publications and an h-index of 85, he is the most-cited researcher in the world in the field of breast cancer. In 2012, Dr. Narod was elected a Fellow of the Royal Society of Canada.
Dr. Narod has studied hereditary breast cancer since 1987 at the International Agency in Research in Cancer in Lyon France with Dr Gilbert Lenoir. He reactivated his career in Canada in 1995 at McGill University under Dr David Rosenblatt working with Dr Patricia Tonin and Dr William Foulkes. He is a co-discoverer of the BRCA1 and BRCA2 genes, and since their discoveries in 1994 and 1995, he has studied the distribution of mutations worldwide. His team have identified founder mutations in the Ashkenazi-Jewish, French-Canadian, and Bahamian populations. His recent research has revealed that one per cent of Jewish women in Ontario carry a BRCA1/2 mutation, that half of these women are not eligible for provincially-funded genetic testing. Most recently, Dr. Narod’s collaborative research showed that women in Poland with BRCA1mutations have a 46 per cent lower risk of breast cancer than women in North America with the same mutation. Dr. Narod’s seminal discoveries have stemmed from both his laboratory and his database – the largest of its kind – of over13,000 women. He has advanced cancer genetics around the world through collaboration with experts in over 30 countries in North America, Asia, Europe, the Caribbean, and Latin America. His research has been instrumental in understanding the role of hereditary factors in breast and ovarian cancer, and he continues to translate the emerging knowledge into more effective strategies for cancer prevention, detection and management. Dr Narod’s influence during the last 15 years has profoundly shaped current knowledge of how to assess breast and ovarian cancer risk and reduce its mortality amongst carriers of BRCA1/2 mutations.
研究兴趣
论文共 1341 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
British Journal of Cancerno. 2 (2024): 269-274
Poster and E-Posters (2024)
JAMA ONCOLOGY (2024)
Jennifer Permuth-Wey,Donghwa Kim,Ya-Yu Tsai,Hui-Yi Lin,Y. Ann Chen,Jill Barnholtz-Sloan, Michael J. Birrer,Gregory Bloom, Stephen J. Chanock,Zhihua Chen,Daniel W. Cramer,Julie M. Cunningham,
crossref(2023)
International journal of molecular sciencesno. 18 (2023)
引用0浏览0WOS引用
0
0
crossref(2023)
crossref(2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn